Cargando…
Short-term results of percutaneous closure of a patent foramen ovale guided by transoesophageal echocardiography in patients with cryptogenic stroke: a retrospective study
BACKGROUND: A patent foramen ovale (PFO) is a risk factor for cryptogenic stroke (CS), and interventional therapy for PFO can reduce the recurrence rate of CS. However, interventional therapies are primarily guided by X-ray imaging, and data on regular post-surgical follow-up with the transthoracic...
Autores principales: | Guo, Yilong, Shi, Zhensu, Zheng, Yin, Xie, Caichan, Yi, Jiao, Chen, Zelun, Shu, Yue, Zhou, Dexing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066844/ https://www.ncbi.nlm.nih.gov/pubmed/35505434 http://dx.doi.org/10.1186/s13019-022-01845-3 |
Ejemplares similares
-
Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017) -
Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019) -
Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale
por: Spencer, Frederick A, et al.
Publicado: (2014) -
Percutaneous Patent Foramen Ovale Closure After Stroke
por: Lee, Oh-Hyun, et al.
Publicado: (2022) -
Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023)